Daily non-political popular news in brief.

Grafts against cancer

A research team led by Université de Montréal Professor Claude Perreault published this week in the Public Library of Science Medicine (PLoS Medicine) a major discovery in Genomics. This discovery provides a sure way of identifying cells that will cause "graft-versus-host disease" (GVHD). This will generate a fundamental impact on the treatment of blood cancers (leukemias and lymphomes) by means of peripheral blood T-cell grafts.

Read more »

Keywords: grafts, cancer, graft

« Previous | Next »

Similar news on "Grafts against cancer":

1. Donors' health associated with risk of infection among recipients of corneal transplants
   02-11-2008 · EurekAlert!
   Corneal grafts obtained from donors dying in the hospital or with cancer may be associated with an increased risk of infection for the recipient, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
   Similar news · Read more »
   
2. Preventing graft-vs.-host disease after bone marrow transplant -- without toxicity
   12-11-2006 · EurekAlert!
   Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
   Similar news · Read more »
   
3. Uncooked fish linked with liver cancer in Asia -- Graft-versus-host disease
   07-09-2007 · EurekAlert!
   The link between eating uncooked fish and liver cancer in South East Asia -- Graft-versus-host disease: a surge of developments.
   Similar news · Read more »
   
4. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
   12-11-2006 · EurekAlert!
   Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
   Similar news · Read more »
   
5. New drug therapy to combat GVHD in stem-cell patients shows significant reduction in deaths
   01-23-2007 · EurekAlert!
   Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. Now, new research from Fred Hutchinson Cancer Research Center shows that adding a widely used topical corticosteroid to the standard treatment for GVHD kept the disease in remission and significantly reduces deaths one year after therapy.
   Similar news · Read more »
   
6. PET/CT use expands: Effectively diagnosing graft infections
   06-04-2007 · EurekAlert!
   Removing infected vascular grafts in patients involves a complex surgical procedure with high risks. Molecular imaging with positron emission tomography/computed tomography effectively diagnoses and differentiates infection, noted Israeli researchers at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.
   Similar news · Read more »
   
7. Freeze-dried tendon implants prove effective in early studies
   01-08-2008 · EurekAlert!
   Donated, freeze-dried tendon grafts loaded with gene therapy may soon offer effective repair of injured tendons, a goal that has eluded surgeons to date. According to study data published today in the journal Molecular Therapy, a new graft technique may provide the first effective framework around which flexor tendon tissue can reorganize as it heals.
   Similar news · Read more »
   
8. Cancer researchers seek safe reduction of radiotherapy
   10-02-2007 · EurekAlert!
   University of Manchester scientists will discuss their research aimed at reducing the side effects of radiotherapy without decreasing its effectiveness at the National Cancer Research Institute conference in Birmingham today Tuesday, Oct. 2, 2007.
   Similar news · Read more »
   
9. Shields Down: A cancer-fighting gene declines in old age
   10-06-2007 · Science News Online
   Decline of an important anti-cancer gene could contribute to increased cancer risk among the elderly.
   Similar news · Read more »
   
10. IMRT better for sparing bladder when treating prostate cancer
    10-09-2007 · EurekAlert!
    When treating early-stage prostate cancer, intensity modulated radiation therapy spares the bladder significantly more from direct radiation when compared to 3-D conformal proton therapy , but the amount of rectal sparing is similar with both treatments, according to a study released in the October issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
    Similar news · Read more »